BIOMAT Database Logo BIOMAT Database Logo

Treatment of keratomycosis with amphotericin B. ointment. 1978

M R Chaddah, and D C Aggarwal

UI MeSH Term Description Entries
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D003320 Corneal Ulcer Loss of epithelial tissue from the surface of the cornea due to progressive erosion and necrosis of the tissue; usually caused by bacterial, fungal, or viral infection. Keratitis, Ulcerative,Keratitides, Ulcerative,Ulcer, Corneal,Ulcerative Keratitides,Ulcerative Keratitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone

Related Publications

M R Chaddah, and D C Aggarwal
Keratomycosis and amphotericin B.
January 1985, Transactions of the American Ophthalmological Society,
M R Chaddah, and D C Aggarwal
Treatmen of keratomycosis with amphotericin B 0.15%.
June 1976, American journal of ophthalmology,
M R Chaddah, and D C Aggarwal
Treatment of fungal corneal ulcers with amphotericin B ointment.
December 1997, American journal of ophthalmology,
M R Chaddah, and D C Aggarwal
Intracameral amphotericin B: initial experience in severe keratomycosis.
October 2001, Cornea,
M R Chaddah, and D C Aggarwal
[Experimental studies of local therapy of Candida keratomycosis with amphotericin B].
August 1987, Klinische Monatsblatter fur Augenheilkunde,
M R Chaddah, and D C Aggarwal
Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.
June 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics,
M R Chaddah, and D C Aggarwal
[AMPHOTERICIN B THERAPY IN KERATOMYCOSIS CAUSED BY ASPERGILLUS FUMIGATUS].
December 1964, Zeitschrift fur arztliche Fortbildung,
M R Chaddah, and D C Aggarwal
Therapeutic efficacy of intracameral amphotericin B injection for 60 patients with keratomycosis.
January 2010, International journal of ophthalmology,
M R Chaddah, and D C Aggarwal
Intracameral amphotericin B injection in the management of deep keratomycosis.
October 2002, Cornea,
M R Chaddah, and D C Aggarwal
In situ Gelling Amphotericin B Nanofibers: A New Option for the Treatment of Keratomycosis.
January 2020, Frontiers in bioengineering and biotechnology,
Copied contents to your clipboard!